Bimeda France

What Bimeda France does

Bimeda France SAS is a French veterinary pharmaceutical and nutritional products company operating as a wholly-owned subsidiary of Ireland-based Bimeda Holdings, a privately held family-owned global animal health group founded in Dublin in 1960. The French entity is headquartered at 12 chemin des Gorges in Dardilly near Lyon, where it operates a manufacturing site that produces and stores the majority of Bimeda France's nutritional products, alongside an ISO 9001-certified quality management system. The product portfolio spans antiparasitics (Bimectin line for cattle, sheep, and pigs), antimicrobials (Bimacure, Bimoxyl LA, Cadorex), anti-inflammatories, sedatives, intramammary treatments, dietary complementary feeds, mineral supplements, milk replacers (Néobion), skin care products, and field diagnostic tools (Bovi-γ-Test). Capitalized at €5,824,050 and registered as SAS under SIRET 791 227 150 00038, the subsidiary has been progressively built through local acquisitions including Zootech (2014), NBVC (2016), and Iodolab (2016).

The company runs a sales-led go-to-market targeting livestock farmers (cattle, sheep, goats, pigs, horses), veterinarians, and to a lesser extent companion animal owners across France. Revenue is generated through one-time product sales of pharmaceuticals and nutritional products, distributed via veterinary professional channels and direct sales teams; pricing is not publicly disclosed. The Dardilly manufacturing site and a small French headcount of 20+ employees are augmented by the parent group's global infrastructure, which includes 11 production sites in 8 countries, 9 R&D centers, and 3 diagnostic laboratories serving 80+ countries across 6 continents.

Bimeda France operates as part of a Tierney family-controlled enterprise that has pursued a sustained acquisition-led global expansion strategy since 1973, adding regional capabilities across the UK, US, Brazil, Kenya, Central America, and most recently South Africa (Afrivet, 2022) and the Nordic region (2021). The group is privately held with no venture capital or public shareholders, and has demonstrated capacity for major capital deployment including a €25 million Chinese sterile injectable facility opened in November 2023 and a €4.8 million UCD research and innovation partnership also in November 2023.

Name

Bimeda France

Legal name

BIMEDA France SAS

Website

https://bimeda.fr

Company type

Private

Founded year

1960

Operating status

Operating

Headcount range

11–50 employees

Short description

Bimeda France SAS manufactures and distributes veterinary pharmaceuticals and nutritional products for livestock farmers and veterinarians across France. Operating as a subsidiary of Ireland-based Bimeda Holdings, the company sells antiparasitics, antibiotics, anti-inflammatories, dietary feeds, and diagnostic tools through veterinary professional and direct sales channels.

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceuticals

NAICS

Animal Food Manufacturing (3111), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (42345)

SIC

Pharmaceutical Preparations (2834), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB)

akta.pro secondary industries

Veterinary Pharmaceutical Wholesalers & Distributors (HLAMAIAA), Antimicrobials & Anti-infectives (HLAMAEAE), Specialty Veterinary Therapeutics Distribution (Oncology, Dermatology, Endocrinology) (HLAMAIAH)

Keywords

• Veterinary pharmaceuticals
• Animal health products
• Livestock medicines
• Veterinary nutrition
• Antimicrobial treatments

Headquarters

HQ city

Dardilly

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Veterinary Pharmaceutical Products: Sale of veterinary pharmaceutical products including antiparasitics, antimicrobials, anti-inflammatories, sedatives, hormones, and intramammary products for livestock and companion animals.
2. Nutritional and Dietary Products: Sale of nutritional products, complementary feeds, mineral dietary foods, and milk replacers for various animal species.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Bimeda France is a wholly-owned French subsidiary (SAS) of Bimeda Holdings that manufactures, markets, and distributes a comprehensive portfolio of veterinary pharmaceutical and nutritional products for livestock and companion animals. The product range spans parasiticides, antimicrobials, anti-inflammatories, sedatives, hormones, intramammary products, dietary complementary feeds, mineral supplements, milk replacers, and diagnostic tools for cattle, sheep, goats, pigs, horses, dogs, and cats. Manufacturing takes place at the ISO 9001-certified Dardilly facility near Lyon, with the broader Bimeda group operating 11 production units and 9 R&D centers globally.

Product overview

Bimeda France is a veterinary pharmaceutical and animal health company that sells and distributes a wide range of nutritional and veterinary pharmaceutical products. The product portfolio includes: parasiticides (Bimectin, Bimectin D, Bimectin Pour-on, Bimectine Pâte, Moxisolv LA, Dectospot), antibiotics (Bimacure, Bimoxyl LA, Cadorex, Macrosyn, Tetroxy Vet, Tylolab tartrate, Cemay), anti-inflammatory medications (Cronyxin, Cronyxin pâte, Emdocam, Recocam, Tolfelab), sedatives (Xylasol), and digestive/metabolic products (Bimestimul, Biorumen Plus, Cosecure Vet, Gastrobim). Nutritional products include colostrum and milk replacers (Néobion, Néobion Pet, OD-Colostrum, Ovibion), mineral feed supplements (Bovargil, Cap Cetotech, Cap Magnésium, CapOligo Longue Action, Capsel Bolus, Capvo'Mag LA, Oroseliod LA, Olixium products, Octabaca, Octalys products, OD products), and diagnostic tools (Bovi-γ-Test, Lecteur Optium Neo H). Skin care products include Zinc Oxide Spray, Dermodoo, and Vagizan. The company operates primarily as a product distributor in France with a manufacturing site in Dardilly near Lyon.

Differentiator

Problem solved

Functional benefit

Products and services

• Bicaman

Quantifiable outcome

• ISO 9001 certification ensuring controlled processes, improved traceability, and recognized product and service quality

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Four partnerships are on record, tiered core and flagship.

• Olivier Wang (Joint Venture Partner)coreStrategic or Co-development Partner · 29 November 2023Local partner in China joint venture for the 25 million euro sterile injectable manufacturing facility in Shijiazhuang, Hebei Province.
• University College Dublin (UCD)flagshipStrategic or Co-development Partner · 10 November 2023Philanthropic partnership establishing the UCD Bimeda Herd Health Hub and AgTechUCD Innovation Center at UCD Lyons Farm in Kildare, Ireland. Bimeda made a substantial donation to UCD Foundation for this 4.8 million euro facility which provides national teaching, research and advisory services for dairy herd health, and supports agri-tech startups and SMEs with access to experimental farm facilities.
• Enterprise IrelandcoreStrategic or Co-development Partner · 1 January 2023Supported the 4.8 million euro UCD Bimeda Herd Health Hub and AgTechUCD Innovation Center investment through Regional Enterprise Development Fund and co-funding with UCD. Government agency supporting Irish enterprise development.
• Rainbow Laboratories LtdcoreTechnology or Integration · 1 January 2019Joint venture partnership establishing a raw material testing and innovation center in Shijiazhuang, China. Bimeda joined with Rainbow Laboratories to create Bimeda-Rainbow Labs testing center supporting quality control and R&D activities for the China manufacturing operations.

Scale indicators10 records

Recent moves9 records

Expansion highlights6 records

Broad incumbents

• Elanco Animal Health: US-listed global animal health company with companion animal and livestock pharmaceutical portfolios. Highly comparable in therapeutic categories and species coverage, though at substantially larger scale than Bimeda France.
• MSD Animal Health: Animal health division of Merck & Co., one of the largest global animal-health players in pharmaceuticals, vaccines, and identification. Competes with Bimeda France across most therapeutic categories but at materially larger scale and broader geographic reach.
• Zoetis: Global leader in animal health, spun out of Pfizer, covering pharmaceuticals, vaccines, diagnostics, and genetics across livestock and companion animals. Overlaps Bimeda France's portfolio but operates at far greater scale and broader scope.
• Phibro Animal Health: US-listed animal health and nutrition company serving livestock and aquaculture producers. Comparable to Bimeda France in nutritional supplements and livestock therapeutics focus, with particular overlap in aquaculture since Bimeda's AquaTactics acquisition.
• Boehringer Ingelheim Animal Health: Animal health business of Boehringer Ingelheim, a global leader in vaccines and therapeutics for livestock and pets. Overlaps directly with Bimeda France's therapeutic and vaccine categories across multiple species.

Direct peers

• Virbac: French-listed veterinary pharmaceutical company offering pharmaceuticals and nutrition across companion and production animals. Closest direct competitor to Bimeda France given shared French heritage, livestock and companion animal focus, and similar product portfolio breadth.
• Dechra Pharmaceuticals: UK-headquartered specialty veterinary pharmaceuticals company with strong focus on therapeutics for companion and production animals. Comparable to Bimeda France in specialty pharma positioning and multi-species portfolio.
• Ceva Santé Animale: French-headquartered global animal health company focused on pharmaceuticals, vaccines, and equipment for livestock and companion animals. Directly comparable to Bimeda France in product mix, French base, and customer segments across cattle, swine, and poultry.
• Vétoquinol: French-listed veterinary pharmaceutical company serving companion and livestock animals. Comparable to Bimeda France in French specialty pharma positioning, mid-cap scale, and emphasis on therapeutic and nutritional categories.

Emerging players

• Norbrook: Privately held UK-based veterinary pharmaceutical manufacturer focused on anti-infectives, anti-inflammatories, and parasiticides for livestock. Closely comparable to Bimeda France in therapeutic product mix and in private mid-cap scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/bimeda-france

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bimeda France